Takeda becomes UNGC signatory in India EP News Bureau Sep 26, 2022 As a signatory, Takeda has committed to adopt the 10 principles of the UNGC
Takeda launches Adynovate to advance prophylaxis treatment for haemophilia patients in India EP News Bureau May 16, 2022 Adynovate, in combination with MYPKFIT, offers personalised treatment, and enables HCPs and patients to monitor factor levels from…
Takeda appoints Serina Fischer as General Manager for India EP News Bureau Mar 2, 2022 Fischer has over 17 years of experience in the biopharma industry, with expertise in strategy, sales, marketing and operations
Alembic Pharmaceuticals receives US FDA tentative approval for Vortioxetine tablets EP News Bureau Jan 7, 2022 The tablets are indicated for the treatment of Major Depressive Disorder (MDD)
US FDA approves Takeda’s Livtencity to treat people with post-transplant Cytomegalovirus infection EP News Bureau Nov 25, 2021 In the phase-III Solstice study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R)…
Takeda partners with JCR Pharmaceuticals to commercialise JR-141 protein EP News Bureau Oct 1, 2021 JR-141 is a potentially-transformative therapy designed to deliver proteins to the brain and peripheral tissues to treat…
Impact of COVID-19 and regulations for OTC segment EP News Bureau Sep 9, 2021 Many pharma companies are inclined to capture the OTC market in India due to the high consumer ratio, but COVID has shifted the…
Moderna might manufacture COVID-19 vaccines in Japan Reuters May 21, 2021 The company is looking into making the vaccine in Asia, including in Japan Moderna Inc is considering manufacturing its…
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData EP News Bureau Sep 13, 2020 Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis
Post-COVID, there will be a mix of various working models EP News Bureau Aug 12, 2020 Koki Sato, Country Head and GM, Takeda India talks about the company’s recent drug launch in India, its plans for the Indian…